Melanoma differentiation associated gene-9 (MDA-9), also known as syntenin, functions as a positive regulator of melanoma progression and metastasis. In contrast, the Raf kinase inhibitor RKIP, a negative modulator of RAF-stimulated MEKK activation, is strongly downregulated in metastatic melanoma cells. In this study, we explored an hypothesized inverse relationship between MDA-9 and RKIP in melanoma. Tumor array and cell line analyses confirmed an inverse relationship between expression of MDA-9 and RKIP during melanoma progression. We found that MDA-9 transcriptionally downregulated RKIP in support of a suggested crosstalk between these two proteins.
Author Manuscript Published OnlineFirst on October 11, 2012; DOI: 10.1158/0008-5472. Melanoma is the sixth most common malignancy with an estimated 76,250 new cases and 9,180 deaths in the United States in 2012 (1) . Once it metastasizes (Stage IV), melanoma is associated with poor prognosis and the overall survival is 8-18 months after diagnosis, depending on the substage (2) . Metastasis is a multifaceted process involving a complex cascade of events (3, 4) and defining the molecular mechanisms underlying melanoma invasion and metastasis are imperative for uncovering specific factors or genes that can augment or suppress melanoma progression. These investigations hold significant potential for developing (5) rational and novel therapeutic approaches for effectively treating advanced cancers. Our prior studies have documented that the expression of melanoma differentiation associated gene-9 (mda-9, also known as syntenin), a PDZ domain-containing scaffold protein, is upregulated during melanoma metastasis and MDA-9 positively regulates tumor progression and metastasis (6) (7) (8) (9) (10) (11) (12) (13) (14) . In addition to melanoma, this distinctive gene is also elevated in multiple additional cancers, including breast and gastric carcinoma, suggesting an expanded involvement of MDA-9 in tumor progression and metastasis (9, 15) . MDA-9 physically interacts with c-Src through its PDZ domains and this interaction increases the assembly of stable c-Src/FAK signaling complexes, initiating a signaling cascade that results in activation of NF-κB and matrix metalloproteinases (MMPs) causing enhanced anchorage independence, cell motility, and metastatic competence in human melanoma cells (13, 14) . Of note, other PDZ domain-containing proteins are also reported to interact with c-Src through PDZ domains and regulate c-Src activity (16) (17) (18) (19) . These provocative findings highlight MDA-9 and its regulated pathways as a functional consequence of interaction with Src as promising therapeutic targets for intervention of metastasis.
In theory, inhibiting a single gene, which allows the completion of any of the pertinent steps in the metastatic cascade, may block metastasis (3) . Evidence to support this possibility comes from studies confirming that loss-of-function (LOF) of specific genes, called metastatic suppressor genes, are important events in acquisition of malignant potential by cancer cells (20) (21) (22) (23) . This paradigm has been further validated by our previous studies where we have documented that inhibition of a single metastasispromoting gene, MDA-9, by an anti-sense approach inhibits melanoma metastasis in vivo in animal models (8, 13) .
Raf kinase inhibitor protein (RKIP) was initially identified as an interacting partner of Raf-1 and as a negative regulator of the mitogen-activated protein kinase (MAPK) cascade initiated by Raf-1 (24) . RKIP is a promising metastasis repressor that regulates several physiological functions. Current evidence indicates that RKIP also cross talks with several important cellular signaling pathways, including NF-κB (20) and Gproteins (25) . A variety of LOF experiments suggest that reduced RKIP function may influence metastasis, angiogenesis, resistance to apoptosis, and genome integrity (26) .
Reconstitution of RKIP expression, gain-of-function (GOF), prevented Matrigel invasion and metastasis in an orthotopic prostate cancer mouse model (27) , without affecting the growth of the primary tumor, thereby establishing RKIP as a potential metastatic suppressor in prostate cancer (27, 28) . RKIP also suppressed metastasis in breast and ovarian cancer models (29, 30) . In melanoma, although reduced levels of RKIP expression correlate with metastatic stage (31) (32) (33) (34) , the underlying molecular mechanisms of RKIP action remain poorly defined.
The purpose of the present study was to analyze whether inhibition of MDA-9 might be a potential target molecule and mechanism of metastasis suppression by RKIP.
We now document that by physically interacting with MDA-9, RKIP inhibits MDA-9-induced activation of downstream signaling molecules, including c-Src, FAK and NF-κB, thereby abrogating metastasis. These intriguing findings indicate that targeted overexpression of RKIP, by genetic or pharmacological means, might be exploited as a potential therapy for metastatic melanoma and other cancers.
Materials and Methods

Cell lines and culture conditions
A clone of normal immortal human melanocytes FM516-SV (referred to as FM-516, was initially provided by Dr. L. Diamond, Wistar Institute, Philadelphia, PA), radial growth phase melanoma WM35 (obtained from Dr. Meenhard Herlyn, Wistar Institute, Philadelphia, PA), vertical growth phase melanoma WM278 and metastatic melanoma FO-1, C8161.9, SK-Mel-28 and MeWo cell lines were cultured as described previously (8) . WM278 and SK-Mel-28 cells were purchased from the American Type Culture Collection (ATCC) (Manassas, VA), MeWo were obtained from Dr. Robert Kerbel, Sunnybrook Cancer Center, Toronto, Canada, FO-1 were provided by Dr. Eliezer Huberman, Argonne National Laboratories, Argonne, IL, and C8161.9 was a gift from Dr. Danny R. Welch, Kansas University Medical Center, KS. All the cells were routinely checked for morphology, in vitro phenotypes (such as invasive and anchorage independent growth) and mycoplasma contamination using a PCR-based mycoplasma detection kit (Applied Biosystems, Foster City, CA).
Plasmid construction and adenoviruses
The mammalian expression plasmid CMV-HA-RKIP with a HA-tag in the amino terminus has been described previously (28, 35) . Deletion mutants of pCMV5-HA-RKIP for expression in mammalian cells were generated by PCR (35) respectively, were prepared as described (36) .
Engineering of RKIP mutant constructs.
Different amino-acid substitutions within the RAF-1 binding site of RKIP, were generated by the QuickChange site-directed mutagenesis kit (Stratagene, Santa Clara, CA) according to the manufacturer's instructions. HA-RKIP was used as template to generate the site-directed mutants.
RNA isolation and qPCR.
Total RNA was extracted using QIAGEN miRNeasy Mini Kit (QIAGEN, Valencia, CA). qPCR was performed using ABI 7900 Fast Real-Time PCR System (Applied Biosystems, Foster City, CA).
Western blotting and co-immunoprecipitations.
Preparation of whole-cell lysates, co-immunoprecipitations and Western blotting were performed as described previously (8, 13, 14 Tissue microarray and immunohistochemistry.
The malignant melanoma tissue microarray (IMH-369) was purchased from
Imgenex Corp (San Diego, CA), and immunostaining was performed as described previously (8) .
Anchorage-independent growth.
Anchorage-independent growth assays were carried out as previously described (8) .
In vitro Cell Invasion.
Cell invasion was determined as described previously (8) in a modified Boyden chamber (BD Bioscience, Bedford, MA, USA) according to the manufacture's instructions.
Chicken embryo chorioallantoic membrane (CAM) assay for chorioallantoic membrane spontaneous lung metastases.
To detect spontaneous lung metastases, we performed CAM assays as described (37, 38) . 
Statistical analysis.
The data are reported as the mean ± S.D. of the values from three independent determinations and statistical analysis was performed using the Student's t test in comparison with corresponding controls. Probability values < 0.05 were considered statistically significant. (Fig. 1C-D) . Consequently, an RKIPpromoter luciferase reporter had significantly lower activity in metastatic human melanoma cell lines than in FM-516 and WM-35 cells, and in the latter two cells infection with Ad.5/3-mda-9 significantly downregulated RKIP-promoter activity (Fig.   1E ). These findings indicate that MDA-9 negatively regulates RKIP expression transcriptionally.
Results
RKIP expression is downregulated in metastatic melanoma
In light of a previous study in prostate cancer (39), we hypothesized and subsequently confirmed through LOF and GOF experiments that Snail, a zinc- transcriptional repressor, plays a critical role in MDA-9-mediated RKIP suppression ( Fig.   2A ). Consistent with a previous study (40) , the MAPK pathway also regulates Snail expression in melanoma cells including both cells with wild-type or mutant BRAF ( Fig.   2B and Fig. S3 ). Based on this consideration, we next investigated how MDA-9 affects Snail expression levels. Consistent with previous observations (41), we found that following contact with fibronectin, ERK was activated by MDA-9 and this activation positively regulated Snail expression (Fig. 2C) subsequently repressing RKIP transcriptionally. For MDA-9-mediated signaling in the context of Src activation, adhesion to fibronectin is important as documented by Boukerche et al., (13) . Consistent with our previous observations, MDA-9 activates ERK1/2 on fibronectin-coated plates, but not on plastic plates, which establishes the rational to perform experiments on fibronectin-coated plates (Fig. S4A) . However, fibronectin-dependence was not evident in BRAF mutant WM278 and SK-Mel-28 cells (Fig. S4B) . To obtain insights relative to persistent overexpression of MDA-9 on RKIP expression in FM-516 cells, several stable mda-9 overexpressing FM-516 clones were established. Two clones, FM-516 mda-9
Cl.10 and Cl.14 express significantly higher levels of mda-9 mRNA and protein compared with parental cells (Fig. S5A and S5B ). Consistent with previous findings (8) , these clones demonstrated significant growth in soft agar as well as invasiveness as compared with parental cells (Fig. S5C and S5D ). As predicted, constitutive RKIP protein and mRNA levels ( Fig. S5A and S5B) , as well as RKIP-promoter luciferase activity (Fig. S5E) , were significantly lower in these two clones compared with parental FM-516 cells. 
Restoration of RKIP activity reduces invasiveness and spontaneous melanoma metastasis. To explore the role of RKIP in melanoma invasion and anchorageindependent growth, highly metastatic C8161.9 and FM-516 mda-9 Cl.14 cells were transiently transfected with a HA-tagged RKIP expression plasmid (HA-RKIP). We confirmed that the HA-RKIP was efficiently expressed in different melanoma cells as documented by immunoblotting at 48 h after construct transfection (Fig. S6A) . It is relevant to mention that this ectopic expression did not effect cell survival after 48 h (Fig.   S6B ). As shown in Fig. 3A and 3B, forced expression of RKIP in these two cell types significantly inhibited their anchorage independent growth and invasive properties. In addition, as expected RKIP overexpression resulted in significant changes in cell morphology and a decrease in intracellular actin staining, suggesting a complete disorganization of the actin cytoskeleton (Fig. S7) . It is worth noting that mutant BRAF expressing WM278 and SK-Mel-28 cells also responded in a similar manner to RKIP as wild type BRAF C8161.9 expressing melanoma cells (Fig. S8A) (Fig. 3C) . Similarly, a significant decrease in lung metastasis was observed upon overexpression of RKIP in both cell types (Fig. 3C) . (Fig. 4A) . Similar effects were also evident in FM516 mda-9 Cl.14 cells upon adhesion to fibronectin (Fig. 4A) . Next, we co-transfected HA-RKIP and mda-9 into FM-516 cells and after 48 h cells were transferred to fibronectin-coated plates and phosphorylation of both Src and FAK was determined. As shown in Fig. 4B , mda-9 alone increased Src and FAK phosphorylation, while HA-RKIP alone did not alter basal levels of Src and FAK phosphorylation, whereas it significantly decreased the mda-9-mediated increases in phosphorylated Src and FAK in FM-516 cells.
These experiments also indicate that although MDA-9 suppressed RKIP expression ( 1C and 1D), RKIP expression did not affect MDA-9 expression (Fig. 4B) . Silencing of MDA-9 by expressing shRNA of mda-9 in C8161.9 cells significantly reduced Src and FAK activation. Concomitantly, ectopic expression of RKIP did not further alter the level of phospho-Src/FAK indicating that RKIP specifically downregulates MDA-9-triggered Src and FAK phosphorylation. Our observations also reveal that RKIP similarly affects the phospo-Src/FAK levels in BRAF mutant cells (Fig. S8B) .
We next studied the effect of RKIP on NF-κB activation, as a consequence of Src and FAK activation, by luciferase reporter assays. As shown in Fig. 4C , transfection of HA-RKIP significantly blocked NF-κB luciferase activity in both FM-516 mda-9 Cl.14 and C8161.9 cells. In FM-516 cells, MDA-9-induced NF-κB luciferase activity, consistent with RKIP function, was down regulated upon co-transfection with HA-RKIP.
However, in the presence of mda-9 shRNA, RKIP failed to down regulate NF-κB luciferase activity in C8161.9 cells further supporting the view that the presence of MDA-9 is required to mediate RKIP action.
RKIP physically interacts with MDA-9. Our finding that the presence of MDA-9 is required to mediate the inhibitory action of RKIP supports the hypothesis that these two proteins might physically interact. To obtain insights into this possible interaction, HA-RKIP and different deletion mutants N60, N93, C134 and C93 (Fig. 5A, Upper panel) were transfected into FM-516 mda-9 Cl.14 and C8161.9 cells. Co-Immunoprecipitation studies revealed that RKIP and MDA-9 physically interact (Fig. 5A ) and interestingly, this interaction significantly blocks MDA-9's ability to interact with c-Src (Fig. 5A) supporting the hypothesis that restoration of RKIP might result in competition with c-Src for binding to MDA-9. Specifically, MDA-9 interacts with C134 and N60, both of which contain the RAF-1 binding site (amino acids 77-108) (5, 42) (Fig. 5A) . Additionally, expression of these constructs also reduces the endogenous MDA-9 and c-Src interaction as verified by immunoprecipitation and immunoblotting assays. As predicted, the N93 and C93 HA-RKIP mutants, that lack the RAF-1 binding domain, display a significantly reduced interaction with MDA-9 without interrupting the MDA-9 and c-Src interaction (Fig. 5A) . Consistent with the immunoprecipitation data, double immunofluorescence using anti-HA and anti-MDA-9 antibodies in HA-RKIP and its different deletion mutants transfected into C8161.9 cells plated on fibronectin also documented co-localization of RKIP and MDA-9, providing further confirmation of interaction between these two proteins (Fig. 5B) . As a corollary, C134 and N60 constructs, that interact with MDA-9, downregulated c-Src and FAK phosphorylation in C8161.9 cells while C93 and N93 constructs were inactive (Fig. 5C) . Similarly, both C134 and N60 deletion mutants reduced anchorage-independent growth and Matrigel invasion of C8161.9 cells, while C93 and N93 mutants did not affect these phenotypes (Fig. 5C ).
PDZ domains bind either the carboxyl-terminal sequences of proteins or internal peptide sequences of their binding partners (35, 43, 44) . Since MDA-9 did not require the C-terminus of RKIP for binding, we hypothesized an involvement of internal PDZ ligands in mediating this specific interaction. To explore any preferential area of binding ) interrupted the interaction with MDA-9 without impairing the binding affinity for RAF-1 (Fig. 6A) . As expected, the expression of this construct did not interfere with the endogenous interaction between MDA-9 and c-Src, as shown by both imunoprecipitation and confocal microscopy ( Fig. 6A and 6B ). In addition, this particular construct has reduced ability to inhibit the anchorage-independent growth and Matrigel invasion of C8161.9 or mda-9 overexpressing FM-516 clones compared to wild type or other mutant RKIP molecules (Fig. 6C) emphasizing the importance of MDA-9 and RKIP interactions in RKIP-mediated suppression of melanoma invasion.
Discussion
We presently reveal a novel mechanism of anti-invasive and anti-metastatic functions of RKIP in melanoma. The anti-metastatic activity of RKIP has been described previously in a number of different cancer models. Li et al. (27) (28) (29) (30) (31) (32) (33) (34) documented that overexpression of RKIP suppressed the ability of human ovarian cancer cells to metastasize when transplanted into nude mice. RKIP overexpression has also been reported to decrease in vitro cell invasion and in vivo development of lung metastases in prostate cancer (27, 28) . However, the molecular mechanism of the anti-metastatic function of RKIP is poorly defined and requires clarification. We presently describe a potential mechanism underlying this activity by documenting that ectopic expression of RKIP can suppress tumor cell invasion and metastasis by interacting with MDA-9, a prometastatic protein, in metastatic melanoma cells (Fig. 7) . dependent Snail activation, MDA-9 suppresses the transcription of RKIP. However, Snail is also transcriptionally regulated by NF-κB (48) , which is activated by MDA-9 (12, 14) and thus, one cannot rule out the possibility that NF-κB is also involved in this process.
We are currently investigating this hypothesis.
We previously documented that upon ECM engagement MDA-9 interacts with cSrc leading to c-Src phosphorylation and FAK auto-phosphorylation (13) . These biochemical changes result in formation of an active focal adhesion complex with resultant activation of the NF-κB pathway and secretion of MMP-2, thereby causing augmented tumor cell motility and metastatic competence. Presently, we document that RKIP physically interacts with MDA-9 inhibiting c-Src phosphorylation and activation of downstream signaling cascades as well as invasion and metastasis. We also confirmed the interaction of RKIP creates a steric interference for c-Src interaction with MDA-9.
However, the detailed molecular mechanism underlying this inhibition will require further experimentation.
RKIP has been reported to inhibit NF-κB activation by three distinct mechanisms. with MDA-9 potentially modulates RKIP interaction with RAF-1 and promotes RAF-1 inhibition. As yet, a potential interaction between RAF-1 and MDA-9 has not been demonstrated and it might be hypothesized that these two proteins reside in mutually exclusive intracellular locations. In this scenario, RKIP might inhibit both protumorigenic RAF-1 and MDA-9, thereby significantly augmenting the tumor suppressor properties of RKIP. In these contexts, overexpression of RKIP using a tumor-specific promoter (49, 50) might be an efficient way to counteract metastatic diseases.
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